|
Volumn 6, Issue 8, 2015, Pages 1420-1426
|
The discovery of a novel antibiotic for the treatment of Clostridium difficile infections: A story of an effective academic-industrial partnership
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
CONGOCIDINE;
DIMINAZENE ACETURATE;
DOUBLE STRANDED DNA;
OLIGONUCLEOTIDE;
PENTAMIDINE;
SMT 19969;
UNCLASSIFIED DRUG;
AMINO ACID SUBSTITUTION;
ANTIBACTERIAL ACTIVITY;
BACTERIAL GROWTH;
BACTERIAL STRAIN;
CLOSTRIDIUM DIFFICILE INFECTION;
CRYSTAL STRUCTURE;
DNA FOOTPRINTING;
DNA SEQUENCE;
DRUG POTENCY;
DRUG STRUCTURE;
ESCHERICHIA COLI;
HUMAN;
HYDROGEN BOND;
KLEBSIELLA;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MOLECULAR INTERACTION;
MOLECULAR MODEL;
MOLECULAR RECOGNITION;
MOLECULAR WEIGHT;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PHARMACOPHORE;
PRIORITY JOURNAL;
PROTEUS MIRABILIS;
PSEUDOMONAS AERUGINOSA;
REVIEW;
STREPTOCOCCUS AGALACTIAE;
STREPTOCOCCUS PYOGENES;
STRUCTURE ANALYSIS;
TRYPANOSOMIASIS;
VANCOMYCIN RESISTANT ENTEROCOCCUS;
X RAY CRYSTALLOGRAPHY;
CLOSTRIDIUM DIFFICILE;
|
EID: 84938895997
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c5md00238a Document Type: Review |
Times cited : (23)
|
References (28)
|